Efficacy and tolerability of intramuscular and oral meloxicam in patients with acute lumbago: a comparison with intramuscular and oral piroxicam

Current Medical Research and Opinion
H C BoschM Hettich

Abstract

In this controlled, randomised, parallel-group, multicentre study, the efficacy and tolerability of an intramuscular (i.m.) dose of meloxicam (15 mg) on Day 1 followed by seven days of oral meloxicam (15 mg/day) were compared with those of an i.m. dose of piroxicam (20 mg) on Day 1 followed by seven days of oral piroxicam (20 mg/day) therapy in a total of 169 outpatients with acute lumbago. Time to onset of analgesic action after i.m. injection was determined, and overall efficacy, pain on movement, limitation of daily activities, local tolerability at the injection site and overall tolerability were assessed by investigators and patients on verbal rating scales (VRSs). Adverse events and laboratory assessments were documented. Meloxicam and piroxicam showed a rapid onset of action after i.m. injection (40 and 45 minutes median time, respectively), overall efficacy of both therapies was highly rated, and limitations to daily life were greatly reduced in the majority of patients in both groups. There were no statistically significant differences in efficacy between meloxicam and piroxicam. Local and overall tolerabilities were equally good for the two drugs, but there were fewer gastrointestinal (GI) adverse events among meloxic...Continue Reading

References

Nov 28, 1990·JAMA : the Journal of the American Medical Association·S M HelfgottJ Nestler
Jan 1, 1995·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·J R Vane, R M Botting
Jan 20, 1994·Nature·J Vane
Apr 3, 1993·BMJ : British Medical Journal·A Frank
Jan 1, 1993·Annual Review of Pharmacology and Toxicology·M D Murray, D C Brater
Jan 12, 1996·Biochemical Pharmacology·G EngelhardtR Utzmann
Jan 12, 1996·Biochemical Pharmacology·G EngelhardtR Utzmann
Apr 1, 1996·British Journal of Rheumatology·D TürckU Busch
Apr 1, 1996·British Journal of Rheumatology·J HosieE Bluhmki
Apr 1, 1996·British Journal of Rheumatology·M DistelJ Fries
Feb 1, 1996·British Journal of Clinical Pharmacology·H NarjesG Nehmiz

❮ Previous
Next ❯

Citations

Jun 3, 1999·The Surgical Clinics of North America·M Kruger, K McRae
Jun 1, 2013·Pain and Therapy·Mehul J DesaiShawnjeet Saini
Sep 24, 1999·The Annals of Pharmacotherapy·B Kaplan-Machlis, B S Klostermeyer
Jul 25, 2018·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·A E KarateevV N Amirdzhanova
Oct 22, 2002·Expert Opinion on Pharmacotherapy·Roy FleischmannGleb Slobodin
Oct 4, 2005·Expert Opinion on Pharmacotherapy·Brian J GatesNeal M Davies
Aug 13, 2003·The American Journal of Hospice & Palliative Care·Howard S Smith, Whitney Baird

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.